Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. May 15, 2025; 17(5): 102647
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102647
Published online May 15, 2025. doi: 10.4251/wjgo.v17.i5.102647
Table 1 General data comparison, mean ± SD/n
General information | Observation group (n = 56) | Control group (n = 56) | t/χ2 | P value |
Average age, years | 68.80 ± 4.11 | 68.70 ± 4.28 | 0.126 | 0.900 |
Gender | ||||
Male | 36 | 31 | 0.929 | 0.335 |
Female | 20 | 25 | ||
ECOG score | 0.175 | 0.982 | ||
1 | 24 | 26 | ||
2 | 18 | 17 | ||
3 | 8 | 7 | ||
4 | 6 | 6 | ||
Average BMI, kg/m² | 20.44 ± 1.11 | 20.28 ± 1.35 | 0.685 | 0.495 |
Tumor location | 0.150 | 0.928 | ||
Stomach | 21 | 23 | ||
Rectum | 18 | 17 | ||
Colon | 17 | 16 | ||
Adjuvant therapy, radiotherapy/chemotherapy | 30/26 | 31/25 | 0.036 | 0.850 |
Tumor stage | 0.000 | 1.000 | ||
Stage I | 30 | 27 | ||
Stage II | 18 | 19 | ||
Stage III | 6 | 7 | ||
Stage IV | 2 | 3 |
- Citation: Zhang S, Li WC, Liu J, Tang Y, Niu DY. Effect of Nutrition Risk Screening 2002-guided enteral nutrition on nutritional status in gastrointestinal tumor patients. World J Gastrointest Oncol 2025; 17(5): 102647
- URL: https://www.wjgnet.com/1948-5204/full/v17/i5/102647.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i5.102647